Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

DaVita Inc.

NYSE

Market Cap.

12.26B

Avg. Volume

795.21K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze DaVita Inc.!

Still processing it, give me a bit more time...

DaVita Inc. News

DaVita Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Care Facilities
davita.com

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc. Earnings & Revenue

DaVita Inc. Financials

Table Compare

Compare DVA metrics with:

   

Earnings & Growth

DVA

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DVA

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DVA

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DVA

None

Debt Ratio

--

--

Quick Ratio

--

--

 

DaVita Inc. Income

DaVita Inc. Balance Sheet

DaVita Inc. Cash Flow

DaVita Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

DaVita Inc. Executives

NameRole
Mr. Javier J. RodriguezChief Executive Officer & Executive Director
Mr. Michael David StaffieriChief Operating Officer of Kidney Care
Mr. Joel AckermanChief Financial Officer & Treasurer
Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer
Mr. James O. HeartyChief Compliance Officer
NameRoleGenderDate of BirthPay
Mr. Javier J. RodriguezChief Executive Officer & Executive DirectorMale19716.71M
Mr. Michael David StaffieriChief Operating Officer of Kidney CareMale19743.02M
Mr. Joel AckermanChief Financial Officer & TreasurerMale19652.11M
Ms. Kathleen Alyce WatersChief Legal & Public Affairs OfficerFemale19681.9M
Mr. James O. HeartyChief Compliance OfficerMale19691.25M

DaVita Inc. Insider Trades

Date15 May
NameArway Pamela M
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameSchechter Adam H
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameMoore Gregory J.
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameNEHRA JOHN M
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameHollar Jason M.
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
DateNameRoleTransactionTypeShares
15 MayArway Pamela MDirectorAcquiredA-Award363
15 MaySchechter Adam HDirectorAcquiredA-Award363
15 MayMoore Gregory J.DirectorAcquiredA-Award363
15 MayNEHRA JOHN MDirectorAcquiredA-Award363
15 MayHollar Jason M.DirectorAcquiredA-Award363

Discover More

Streamlined Academy

DaVita Inc.

NYSE

Market Cap.

12.26B

Avg. Volume

795.21K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

DaVita Inc. News

DaVita Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

DaVita Inc. Earnings & Revenue

DaVita Inc. Income

DaVita Inc. Balance Sheet

DaVita Inc. Cash Flow

DaVita Inc. Financials Over Time

DaVita Inc. Executives

NameRole
Mr. Javier J. RodriguezChief Executive Officer & Executive Director
Mr. Michael David StaffieriChief Operating Officer of Kidney Care
Mr. Joel AckermanChief Financial Officer & Treasurer
Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer
Mr. James O. HeartyChief Compliance Officer
NameRoleGenderDate of BirthPay
Mr. Javier J. RodriguezChief Executive Officer & Executive DirectorMale19716.71M
Mr. Michael David StaffieriChief Operating Officer of Kidney CareMale19743.02M
Mr. Joel AckermanChief Financial Officer & TreasurerMale19652.11M
Ms. Kathleen Alyce WatersChief Legal & Public Affairs OfficerFemale19681.9M
Mr. James O. HeartyChief Compliance OfficerMale19691.25M

DaVita Inc. Insider Trades

Date15 May
NameArway Pamela M
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameSchechter Adam H
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameMoore Gregory J.
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameNEHRA JOHN M
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
Date15 May
NameHollar Jason M.
RoleDirector
TransactionAcquired
TypeA-Award
Shares363
DateNameRoleTransactionTypeShares
15 MayArway Pamela MDirectorAcquiredA-Award363
15 MaySchechter Adam HDirectorAcquiredA-Award363
15 MayMoore Gregory J.DirectorAcquiredA-Award363
15 MayNEHRA JOHN MDirectorAcquiredA-Award363
15 MayHollar Jason M.DirectorAcquiredA-Award363

Streamlined Academy

Website screenshot
HealthcareMedical - Care Facilities
davita.com

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze DaVita Inc.!

Still processing it, give me a bit more time...

DaVita Inc. Financials

Table Compare

Compare DVA metrics with:

   

Earnings & Growth

DVA

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DVA

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DVA

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DVA

None

Debt Ratio

--

--

Quick Ratio

--

--

 

DaVita Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More